Filter posts

Washington Post: Crowdsourcing Medical Decisions

On Monday, Ariana Eunjung Cha wrote about the difficult ethical issue of Compassionate Use, which allows a …

AIR 340B: New Analysis Shows Most 340B Hospitals Provide Little Charity Care

Today, the Alliance for Integrity and Reform of 340B (AIR 340B) released a new report, …

Promising News for Babies Born HIV-Positive

This week, scientists announced that they have cleared HIV in a Long Beach, Calif.-baby who …

Rare Disease Day 2014: Joining Together for Better Care

There are more than 6,000 different rare diseases affecting over 60 million people across Europe …

Partnership for Part D Access Launches Today

BIO joins patient groups and other health care stakeholders today to announce the formation of …

Physician Payments Sunshine Act: Collaboration Key for Doctors & Biopharmas

In a letter to the editor on USA Today, BIO CEO Jim Greenwood and John …

National Health Interview Survey: Adult Vaccination Rates Need Boost

The Centers for Disease Control and Prevention (CDC) recently released immunization coverage estimates from the …

Fireside Chat with Allergan CEO, David Pyott

Day two of the 16th Annual BIO CEO & Investor Conference​ kicked off with a Fireside Chat featuring one …

4 Tips for Building a Successful Biotech: Richard Pops of Alkermes at #BIOCEO14

The 16th Annual BIO CEO & Investor Conference opened with a fireside chat between Richard …

FDA Week: For Biologics, A Name Isn't Just A Name (Jim Greenwood op-ed)

What is in a name? Names help make medicinal products more easily distinguishable by doctors, …